These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15457278)

  • 41. Detection of coronary microembolization by Doppler ultrasound in patients with stable angina pectoris undergoing elective percutaneous coronary interventions.
    Bahrmann P; Werner GS; Heusch G; Ferrari M; Poerner TC; Voss A; Figulla HR
    Circulation; 2007 Feb; 115(5):600-8. PubMed ID: 17261655
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predictors and prognostic significance of troponin-I release following elective coronary angioplasty.
    Izgi A; Tanalp AC; Kirma C; Dundar C; Oduncu V; Akcakoyun M; Ozveren O; Mutlu B
    J Int Med Res; 2006; 34(6):612-23. PubMed ID: 17294993
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic implication of creatine kinase elevation following elective coronary artery interventions.
    Kong TQ; Davidson CJ; Meyers SN; Tauke JT; Parker MA; Bonow RO
    JAMA; 1997 Feb; 277(6):461-6. PubMed ID: 9020269
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Different prognostic importance of elevated troponin I after percutaneous coronary intervention in acute coronary syndrome and stable angina pectoris.
    Gravning J; Ueland T; Mørkrid L; Endresen K; Aaberge L; Kjekshus J
    Scand Cardiovasc J; 2008 Jun; 42(3):214-21. PubMed ID: 18569954
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence and prognostic significance of preprocedural cardiac troponin elevation among patients with stable coronary artery disease undergoing percutaneous coronary intervention: results from the evaluation of drug eluting stents and ischemic events registry.
    Jeremias A; Kleiman NS; Nassif D; Hsieh WH; Pencina M; Maresh K; Parikh M; Cutlip DE; Waksman R; Goldberg S; Berger PB; Cohen DJ;
    Circulation; 2008 Aug; 118(6):632-8. PubMed ID: 18645057
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Measuring aspirin resistance, clopidogrel responsiveness, and postprocedural markers of myonecrosis in patients undergoing percutaneous coronary intervention.
    Buch AN; Singh S; Roy P; Javaid A; Smith KA; George CE; Pichard AD; Satler LF; Kent KM; Suddath WO; Waksman R
    Am J Cardiol; 2007 Jun; 99(11):1518-22. PubMed ID: 17531573
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Protection from procedural myocardial injury by omega-3 polyunsaturated fatty acids (PUFAs): is related with lower levels of creatine kinase-MB (CK-MB) and troponin I?
    Foroughinia F; Salamzadeh J; Namazi MH
    Cardiovasc Ther; 2013 Oct; 31(5):268-73. PubMed ID: 23134549
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Release of creatine kinase-MB and cardiac specific troponin-I following percutaneous transluminal coronary angioplasty.
    Hunt AC; Chow SL; Shiu MF; Chilton DC; Cummins B; Cummins P
    Eur Heart J; 1991 Jun; 12(6):690-3. PubMed ID: 1860469
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Troponin T, Troponin I and CK-MB (mass) in the detection of periprocedural myocardial damage after coronary angioplasty].
    La Vecchia L; Bedogni F; Finocchi G; Mezzena G; Martini M; Sartori M; Castellani A; Soffiati G; Vincenzi M
    Cardiologia; 1997 Apr; 42(4):405-13. PubMed ID: 9244645
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic significance of small troponin I rise after a successful elective percutaneous coronary intervention of a native artery.
    De Labriolle A; Lemesle G; Bonello L; Syed AI; Collins SD; Ben-Dor I; Pinto Slottow TL; Xue Z; Torguson R; Suddath WO; Satler LF; Kent KM; Pichard AD; Lindsay J; Waksman R
    Am J Cardiol; 2009 Mar; 103(5):639-45. PubMed ID: 19231326
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sensitivity and long-term prognostic value of cardiac troponin-I increase shortly after percutaneous transluminal coronary angioplasty.
    Attali P; Aleil B; Petitpas G; DePoli F; Wiesel ML; Wuillermin A; Cazenave JP; Mossard JM
    Clin Cardiol; 1998 May; 21(5):353-6. PubMed ID: 9595219
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic importance of troponin T and creatine kinase after elective angioplasty.
    Nienhuis MB; Ottervanger JP; Dikkeschei B; Suryapranata H; de Boer MJ; Dambrink JH; Hoorntje JC; van 't Hof AW; Gosselink M; Zijlstra F
    Int J Cardiol; 2007 Aug; 120(2):242-7. PubMed ID: 17182137
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A pilot randomized study of ranolazine for reduction of myocardial damage during elective percutaneous coronary intervention.
    Pelliccia F; Pasceri V; Marazzi G; Rosano G; Greco C; Gaudio C
    Am Heart J; 2012 Jun; 163(6):1019-23. PubMed ID: 22709755
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relation of endothelial function to residual platelet reactivity after clopidogrel in patients with stable angina pectoris undergoing percutaneous coronary intervention.
    Muller O; Hamilos M; Bartunek J; Ulrichts H; Mangiacapra F; Holz JB; Ntalianis A; Trana C; Dierickx K; Vercruysse K; De Bruyne B; Wijns W; Barbato E
    Am J Cardiol; 2010 Feb; 105(3):333-8. PubMed ID: 20102944
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Direct coronary stenting versus stenting with balloon pre-dilation: incidence of enzyme release and follow-up results of a multicentre, prospective, randomized study. The CK and Troponin I Estimation in direct STenting (CK TEST) trial.
    Balducelli M; Varani E; Vecchi G; Paloscia L; Manari A; Santarelli A; Cappi B; Shoeib A; Valenti S; Maresta A;
    Minerva Cardioangiol; 2007 Jun; 55(3):281-9. PubMed ID: 17534246
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cardiovascular outcome in hospitalized patients with minimal troponin I elevation and normal creatine phosphokinase.
    Srivathsan K; Showalter J; Wilkens J; Hurley B; Abbas A; Loutfi H
    Int J Cardiol; 2004 Nov; 97(2):221-4. PubMed ID: 15458687
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Significance of cardiac troponin I and creatine kinase release after coronary intervention.
    Wu CJ; Liang HL; Chiou KR; Mar GY; Tseng CJ; Lin SL; Chiang HT; Liu CP
    Zhonghua Yi Xue Za Zhi (Taipei); 2001 Jun; 64(6):343-50. PubMed ID: 11534802
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Changes in serum cardiac troponin I levels after percutaneous transluminal coronary angioplasty.
    Yang Z; Jia Y; Zhang J; Cao K; Zhang F; Ma G; Ma W
    Chin Med J (Engl); 1999 Nov; 112(11):1049-51. PubMed ID: 11721471
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Point-of-care assessment of platelet reactivity after clopidogrel to predict myonecrosis in patients undergoing percutaneous coronary intervention.
    Mangiacapra F; Barbato E; Patti G; Gatto L; Vizzi V; Ricottini E; D'Ambrosio A; Wijns W; Di Sciascio G
    JACC Cardiovasc Interv; 2010 Mar; 3(3):318-23. PubMed ID: 20298992
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Protective role of chronic statin therapy in reducing myocardial damage during percutaneous coronary intervention.
    Auguadro C; Manfredi M; Scalise F; Mortara A; Specchia G
    J Cardiovasc Med (Hagerstown); 2006 Jun; 7(6):416-21. PubMed ID: 16721204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.